跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
IMFINZI 50 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION
Approved
STANDARD
IMFINZI 50 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION
Astrazeneca Ab
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Nov 3, 2020
Approval ID
6cbb5f5168172f5a
Company
Astrazeneca Ab
Type
Standard
Approval Details
Approval Id
6cbb5f5168172f5a
Drug Cima Aemps Name
IMFINZI 50 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number
1181322001IP
Holder Company Name
Astrazeneca Ab
Marketing Company Name
Abacus Medicine A/S
Holder Company Detail Path
/organization/astrazeneca-ab
Authorization Date
2020-11-03
Dosage Form
CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose
50 mg/ml
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Astrazeneca Ab
Company Detail Path
/organization/astrazeneca-ab
Company Information
Pharmaceutical Company Name
AstraZeneca AB
Name En
AstraZeneca AB
Country Name
Spain
City Name
madrid,madrid,country_es
Address
CALLE RAIMUNDO FERNANDEZ VILLAVERDE 63
Website
http://www.astrazeneca.se
Active Ingredients
DURVALUMAB
500 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Nov 3, 2020
Approval ID
6cbb5f5168172f5a
Type
Standard
Back to CIMA-AEMPS Approvals
IMFINZI 50 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION - CIMA-AEMPS Drug Approval Details
